AWESOME AWESOME AWESOME!!!!
And people say Magden is no good.....silly peoples.
Thanks for the build!!!
AWESOME AWESOME AWESOME!!!!
And people say Magden is no good.....silly peoples.
Thanks for the build!!!
Actually what people say is that Magden's aren't great without the bear + Master Architect. With those two things their dps is known to be fairly good and comparable to a magsorc and magdk.
AWESOME AWESOME AWESOME!!!!
And people say Magden is no good.....silly peoples.
Thanks for the build!!!
BackLotBasher wrote: »Thanks for the video. I have a stamina warden, but I've also been bringing up a magicka warden in coop with some friends. Really like the pool of interesting spells. Maybe you can help...I wouldn't be anywhere near endgame for gear, and only around 200 CP. Am I still able to make this work for grinding through that part of the game?
Second, without access to this Master Architect gear, are there any crafted sets that offer some similar boosts, even if they aren't as good? I have a crafting alt with 8 (no nirhoned) traits in most categories.
MLGProPlayer wrote: »Still less DPS than every other class (magplars are parsing 49k this patch...), and no AOE ultimate or group utility (other than the major slayer which comes from a set, and not the class itself).
The class is still in a very bad place and needs some serious buffs. It's not useless, of course, but it's definitely the worst DPS class in the game.
BackLotBasher wrote: »MLGProPlayer wrote: »Still less DPS than every other class (magplars are parsing 49k this patch...), and no AOE ultimate or group utility (other than the major slayer which comes from a set, and not the class itself).
The class is still in a very bad place and needs some serious buffs. It's not useless, of course, but it's definitely the worst DPS class in the game.
Is the magplar a better overall class to use? I'm not really up on all the fine points of dps comparisons. I do have a magplar high elf that I haven't played for a bit. I seem to recall using it more as a healer.
MLGProPlayer wrote: »AWESOME AWESOME AWESOME!!!!
And people say Magden is no good.....silly peoples.
Thanks for the build!!!
Still less DPS than every other class (magplars are parsing 49k this patch...), and no AOE ultimate or group utility (other than the major slayer which comes from a set, and not the class itself).
The class is still in a very bad place and needs some serious buffs. It's not useless, of course, but it's definitely the worst DPS class in the game.
stileanima wrote: »MLGProPlayer wrote: »AWESOME AWESOME AWESOME!!!!
And people say Magden is no good.....silly peoples.
Thanks for the build!!!
Still less DPS than every other class (magplars are parsing 49k this patch...), and no AOE ultimate or group utility (other than the major slayer which comes from a set, and not the class itself).
The class is still in a very bad place and needs some serious buffs. It's not useless, of course, but it's definitely the worst DPS class in the game.
I'm curious where you are getting this Magplar number from to be honest and would love to see some screenshots. The only 49k parse I've seen is from Alcast on a 3mil target, who used the Lover mundus in that particular test, finishing off with over 17k penetration, and also no resources left (in short, not a sustainable rotation for trials). In my test, I had only 12k pen and demonstrated a sustainable rotation on a 6mil target, just for comparison.
stileanima wrote: »https://www.youtube.com/watch?v=m3RXRc_7PtI
Finally updated my build for Summerset.
Please feel free to ask me any questions if you've got them!
Problem is, as I said above, that you have to alter your rotation and drop a necessary skill to slot some healing on a warden. If I go downstairs for example, I have to use living trellis to survive there. On magblade, I have enough healing with funnel health and refreshing path, which dates not reduce my dps significantly. On any other class, sorc, dk, warden, templar, I have to slot something extra. This is one reason why nightblades are as good as they are in the newer trials.